✦ LIBER ✦

PMH35 Cost-Effectiveness of Agomelatine in Treatment of Major Depressive Disorders in Turkey

✍ Scribed by M. Tatar; N. Dilbaz; E.T. Oral; M. Tan

Book ID: 119311416
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 58 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.03.480

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH32 Cost-Effectiveness of Agomelatine

PMH32 Cost-Effectiveness of Agomelatine in the Treatment of Major Depressive Episodes in Thailand

✍ B. Prukkanone; T. Kongsuk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PMH39 THE COST-UTILITY OF AGOMELATINE IN

PMH39 THE COST-UTILITY OF AGOMELATINE IN MAJOR DEPRESSIVE DISORDER IN POLAND

✍ Golicki, D; Pajaąk, K; Dbrowska, A; Niewada, M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PMH26 COST-EFFECTIVENESS ANALYSIS OF ESC

PMH26 COST-EFFECTIVENESS ANALYSIS OF ESCITALOPRAM IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER IN TURKEY

✍ ME Hemels; O Karamustafaloglu; E Ozmen; S Dilsad; S Mene 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PMH30 ECONOMIC EVALUATION OF AGOMELATINE

PMH30 ECONOMIC EVALUATION OF AGOMELATINE IN MAJOR DEPRESSIVE DISORDERS IN IRELAND

✍ Alegre, P; Lacey, L; McAuliffe, A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Agomelatine in the Treatment of Major De

Agomelatine in the Treatment of Major Depressive Disorder

✍ Kennedy, Sidney H.; Rizvi, Sakina J. 📂 Article 📅 2010 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 237 KB

Agomelatine in the Treatment of Major De

Agomelatine in the Treatment of Major Depressive Disorder

✍ Kennedy, Sidney H.; Rizvi, Sakina J. 📂 Article 📅 2010 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 237 KB

To demonstrate the clinical effectiveness of an antidepressant drug requires evidence beyond short- and long-term efficacy, including a favourable adverse-effect profile and sustained treatment adherence. Under these conditions, patients should experience enhanced social and functional outcomes. The